Nuvation Bio Appoints Philippe Sauvage as Chief Financial Officer
Key Highlights Philippe Sauvage brings over 20 years of leadership in finance and operations within global biopharma and healthcare. Formerly Global Head…
Browsing Tag
David Hung
2 posts
Nuvation Bio Acquires AnHeart: A Milestone in Oncology
Key Highlights Nuvation Bio to acquire AnHeart in an all-stock deal, with closing expected in Q2 2024, enhancing its…